Based on SEC filing data. A biotech corporation based in South San Francisco has raised $150 million in equity funding and is in the growth stage of development.
Get notified the moment FLX Bio, Inc. (RAPT) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.